Tel +1.201.308.8775
E-mail njadmin@njipla.org

New Jersey Intellectual Property Law Association (NJIPLA)
c/o RRR Associations, LLC
2125 Center Avenue, Suite 616, Fort Lee, NJ, 07024

The Impact of PTAB Proceedings on Bio/Pharma Litigation and Strategy

  • 02/17/2021
  • 1:00 PM - 2:00 PM
  • GoToWebinar

Registration


Register

Annual PTAB Webinar Series: The Impact of PTAB Proceedings on Bio/Pharma Litigation and Strategy

While AIA proceedings are a popular mechanism to challenge patents, their use and influence in the bio/pharma space has been different than in other technology areas. As these proceedings have matured and evolved over the years, their influence in the bio/pharma space has evolved as well. Join us as we discuss the following topics:

  • A review of how bio/pharma patents have fared before the PTAB;
  • An analysis of how PTAB proceedings are impacting ANDA and biosimilar litigations;
  • A discussion of how recent precedential PTAB decisions are impacting PTAB invalidity proceedings in the bio/pharma space;
  • A discussion of expectations and potential strategies going forward.


Earn up to 1.0 Professional CLE for NJ/NY/PA

Speaker

Alison J. Baldwin is a partner with McDonnell Boehnen Hulbert & Berghoff LLP. Ms. Baldwin brings nearly two decades of experience to in the pharmaceutical and agricultural spaces to your intellectual property project. Her background in biotechnology and plant science allows her to have a unique understanding of the needs and challenges faced by the firm’s pharmaceutical, agriculture, food, cannabis and biofuel clients. Eat it, Drink it, Wear it, Smoke it, or Drive it – Ms. Baldwin has advised clients in that field. [Read More]

Moderator Matthew Hartman, Counsel, Akin Gump, NJIPLA Chair, PTAB Committee

GoToWebinar Note: Once you register, you will receive a GoToWebinar confirmation e-mail with a unique link to join the session. Click "Add to calendar" to ensure you don't miss the webinar.